HOME >> MEDICINE >> NEWS
Cholesterol-lowering drugs should revolutionise treatment of heart attack and stroke

Results of a landmark study published in the July 6 issue of THE LANCET highlight how the prescribing of statins to lower blood cholesterol could reduce rates of heart attack and stroke by at least a third.

Vascular disease is the leading cause of death in many countries. Statins are usually only given to people who have heart disease and raised blood cholesterol. New findings from the Heart Protection Study (HPS) led by Rory Collins from the University of Oxford's Clinical Trial Service Unit show that statins also reduce the risk of heart attack and stroke in people who have diabetes, arterial disease, or in individuals who have previously had a stroke. Most strikingly, the study found substantial benefits even among those high-risk patients considered to have "normal" or "low" blood cholesterol concentrations. The HPS study provides definite evidence that guidelines should be changed so that a statin is considered for anybody at an increased risk of heart attack or stroke-regardless of their blood cholesterol concentration.

Over 20,000 UK adults (aged 40-80) with coronary disease, other occlusive arterial disease, or diabetes were randomly allocated to receive daily doses of 40 mg simvastatin or placebo for five years. Death from all causes was reduced from 14.7% (for patients given placebo) to 12.9% (for patients given simvastatin), mainly due to an 18% relative reduction in the coronary death rate in patients assigned simvastatin.

There were also relative reductions of around 25% for non-fatal heart attack or coronary death, for non-fatal or fatal stroke, and for coronary or non-coronary revascularisation. Simvastatin was well tolerated with no major side-effects, and its benefits were additional to those of other cardioprotective treatments such as aspirin, - -blockers, and ACE inhibitors.

HPS also assessed the effects of using antioxidant vitamin supplements (600mg vitamin E, 250mg vitamin C and 20mg beta-carotene daily) in people
'"/>

Contact: Richard Lane
richard.lane@lancet.com
44-20-7424-4949
Lancet
4-Jul-2002


Page: 1 2 3

Related medicine news :

1. Cholesterol-lowering drug may also reduce risk of blood clots
2. Cholesterol-lowering drug may slow Alzheimers progression
3. Cholesterol-lowering medications may reduce risk of glaucoma
4. Cholesterol-lowering drugs may help stroke patients get well
5. Cholesterol-lowering drugs safe and effective in children
6. Cholesterol-lowering drugs provide double protection against heart disease
7. UW research shows risk factors for relapse among health care professionals who abuse drugs
8. New studies show mixed results on epilepsy drugs and birth defects
9. Newly discovered pathway might help in design of cancer drugs
10. Study examines consequences of Thailands war on drugs
11. Computational tool predicts how drugs work in cells, advancing efforts to design better medicines

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/2/2020)... NEW ORLEANS (PRWEB) , ... April 02, 2020 ... ... opioids while fetuses in their mother’s womb are encouraging their parents, grandparents, and ... compensation from Purdue—reportedly up to $6 billion in funds will be made available ...
(Date:4/1/2020)... ... April 01, 2020 , ... American hospital workers are in ... patients. , Staffers are in particular need of face shields, which protect them ... Wall Street Journal reported that New York City mayor Bill de Blasio's office ...
(Date:3/30/2020)... DIEGO (PRWEB) , ... March 30, 2020 , ... ... to new and prospective patients, continuing its commitment to provide comprehensive and compassionate ... , Patients can use Achieve Medical Center’s UpDox platform for telemedicine services including ...
(Date:3/28/2020)... VALLEY, N.Y. (PRWEB) , ... March 27, 2020 ... ... to protect workers and the public from the spread of the coronavirus. Operating ... Cuomo, crews are pressing forward with infrastructure renewal and environmental protection projects in ...
(Date:3/28/2020)... ... March 28, 2020 , ... Confluent ... (EPPTS), a physical therapist-owned rehabilitation company since 1985 specializing in the treatment of ... “Since we started more than 30 years ago, we have been committed to ...
Breaking Medicine News(10 mins):
(Date:3/30/2020)... , ... March 30, 2020 , ... ... it has been recognized by Dresner Advisory Services as the #2 vendor in ... capabilities related to data orchestration, data transformation, and data integration for a variety ...
(Date:3/30/2020)... ... March 30, 2020 , ... “In the time of remote ... hear stories from our customers of vendor price-gouging. We are here to promise ... hardships in this difficult time,” says Borya Shakhnovich, CEO of airSlate -- parent ...
(Date:3/30/2020)... , ... March 30, 2020 , ... ... Aspire Regenerative now offers telemedicine appointments in addition to in-person visits. ... that the safety and well-being of patients, health care professionals, and the community ...
Breaking Medicine Technology:
Cached News: